"Inflammatory Carcinoma" of the Breast, The American Journal of Cancer, vol.33, issue.1, pp.33-49, 1938. ,
DOI : 10.1158/ajc.1938.33
Inflammatory carcinoma of the breast: a report of twenty-? eight cases from the breast clinic of Memorial Hospital, Surg Gynecol Obstet, vol.39, p.580, 1924. ,
Epidemiology of Inflammatory Breast Cancer (IBC)1, Breast Disease, vol.22, issue.1, pp.9-23, 2005. ,
DOI : 10.3233/BD-2006-22103
Inflammatory breast cancer: a single centre analysis. Asian Pac, J ,
Trends for Inflammatory Breast Cancer: Is Survival Improving?, The Oncologist, vol.12, issue.8, pp.904-912, 2007. ,
DOI : 10.1634/theoncologist.12-8-904
Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer Database, Journal of Clinical Oncology, vol.32, issue.19, pp.2018-2024, 2014. ,
DOI : 10.1200/JCO.2014.55.1978
Population-Based Statistics for Women Diagnosed with Inflammatory Breast Cancer (United States), Cancer Causes & Control, vol.15, issue.3, pp.321-328, 2004. ,
DOI : 10.1023/B:CACO.0000024222.61114.18
Influence of pregnancy on the outcome of breast cancer: a case-? control study ,
Inflammatory Breast Cancer: Yet Another Risk of the Obesity Epidemic?, JNCI Journal of the National Cancer Institute, vol.105, issue.18, pp.1340-1342, 2013. ,
DOI : 10.1093/jnci/djt236
Inflammatory Breast Cancer, Seminars in Radiation Oncology, vol.19, issue.4, pp.256-265, 2009. ,
DOI : 10.1016/j.semradonc.2009.05.008
Risk Factors for Inflammatory Breast Cancer and Other Invasive Breast Cancers, JNCI Journal of the National Cancer Institute, vol.105, issue.18, pp.1373-1384, 2013. ,
DOI : 10.1093/jnci/djt206
Does Secondary Inflammatory Breast Cancer Represent Post-Surgical Metastatic Disease?, Cancers, vol.4, issue.4, pp.156-164, 2012. ,
DOI : 10.3390/cancers4010156
Defining the Clinical Diagnosis of Inflammatory Breast Cancer, Seminars in Oncology, vol.35, issue.1, pp.7-10, 2008. ,
DOI : 10.1053/j.seminoncol.2007.11.010
Trends in Inflammatory Breast Carcinoma Incidence and Survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute, JNCI Journal of the National Cancer Institute, vol.97, issue.13, pp.966-975, 2005. ,
DOI : 10.1093/jnci/dji172
The inflammatory breast: Management, decision-making algorithms, therapeutic principles, Diagnostic and Interventional Imaging, vol.93, issue.2, pp.126-136, 2012. ,
DOI : 10.1016/j.diii.2011.12.005
Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition?, International Journal of Cancer, vol.33, issue.4, pp.382-385, 1995. ,
DOI : 10.1002/ijc.2910620404
Inflammatory Breast Cancer: What We Know and What We Need to Learn, The Oncologist, vol.17, issue.7, pp.891-899, 2012. ,
DOI : 10.1634/theoncologist.2012-0039
Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets, Clinical Cancer Research, vol.19, issue.17, pp.4685-4696, 2013. ,
DOI : 10.1158/1078-0432.CCR-12-2549
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer, Breast Cancer Research, vol.15, issue.1, p.68, 2010. ,
DOI : 10.1038/nm0809-842
Molecular Heterogeneity of Inflammatory Breast Cancer: A Hyperproliferative Phenotype, Clinical Cancer Research, vol.12, issue.17, pp.5047-5054, 2006. ,
DOI : 10.1158/1078-0432.CCR-05-2248
E-?cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking, Anticancer Res, vol.30, pp.3903-3910, 2010. ,
Immunophenotypic analysis of inflammatory breast cancers: identification of an???inflammatory signature???, The Journal of Pathology, vol.202, issue.3, pp.265-273, 2004. ,
DOI : 10.1002/path.1515
Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease, Cancer, vol.68, issue.9, pp.1922-1927, 2006. ,
DOI : 10.1002/1097-0142(19891101)64:9<1922::AID-CNCR2820640927>3.0.CO;2-I
Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: Prognostic significance, International Journal of Cancer, vol.49, issue.2, pp.201-208, 1989. ,
DOI : 10.1002/ijc.2910430205
The Role of Inflammation in Inflammatory Breast Cancer, Adv. Exp. Med. Biol, vol.816, pp.53-73, 2014. ,
DOI : 10.1007/978-3-0348-0837-8_3
Breast tumour angiogenesis, Breast Cancer Research, vol.11, issue.Suppl 5, p.216, 2007. ,
DOI : 10.1186/bcr1796
Microvessel density, expression of estrogen receptor alpha, MIB-?1, p53, and c-?erbB-?2 in inflammatory breast cancer, Clin. Cancer Res. Off. J. Am ,
Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression, British Journal of Cancer, vol.88, issue.5, pp.718-725, 2003. ,
DOI : 10.1038/sj.bjc.6600807
Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer, Oncogene, vol.21, issue.49, pp.7593-7597, 2002. ,
DOI : 10.1038/sj.onc.1205932
p53 Expression as a Prognostic Marker in Inflammatory Breast Cancer, Clinical Cancer Research, vol.10, issue.18, pp.6215-6221, 2004. ,
DOI : 10.1158/1078-0432.CCR-04-0202
Molecular biology of breast cancer metastasis Inflammatory breast cancer: clinical syndrome and molecular determinants, Breast Cancer Research, vol.1, issue.6, pp.423-429, 2000. ,
DOI : 10.1007/BF02096306
A novel putative low-?affinity insulin-?like growth factor-? binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.5, pp.2511-2519, 1999. ,
RhoC GTPase Overexpression Modulates Induction of Angiogenic Factors in Breast Cells, Neoplasia, vol.2, issue.5 ,
DOI : 10.1038/sj.neo.7900115
RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast, Breast Cancer Research and Treatment, vol.2, issue.Pt2, pp.101-110, 2005. ,
DOI : 10.1007/s10549-005-4170-6
Nuclear Factor-??B Signature of Inflammatory Breast Cancer by cDNA Microarray Validated by Quantitative Real-time Reverse Transcription-PCR, Immunohistochemistry, and Nuclear Factor-??B DNA-Binding, Clinical Cancer Research, vol.12, issue.11, pp.3249-3256, 2006. ,
DOI : 10.1158/1078-0432.CCR-05-2800
Human Cytomegalovirus Infection Enhances NF-??B/p65 Signaling in Inflammatory Breast Cancer Patients, PLoS ONE, vol.1, issue.2, p.55755, 2013. ,
DOI : 10.1371/journal.pone.0055755.s001
Presence of anaplastic lymphoma kinase in inflammatory breast cancer, SpringerPlus, vol.2, issue.1, 2013. ,
DOI : 10.1021/pr7008127
Inflammatory breast carcinoma, Proc. Bayl. Univ ,
Clinical, and Pathologic Findings in 142 Cases, Radiology, vol.223, pp.829-838, 2002. ,
Primary Inflammatory Carcinoma of the Breast, American Journal of Roentgenology, vol.174, issue.2, pp.535-538, 2000. ,
DOI : 10.2214/ajr.174.2.1740535
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings, Breast Cancer Research and Treatment, vol.7, issue.3, pp.417-426, 2008. ,
DOI : 10.1007/s10549-007-9671-z
Initial evaluation of inflammatory breast cancer with fluorodeoxyglucose positron emission tomography, Indian Journal of Nuclear Medicine, vol.27, issue.1 ,
DOI : 10.4103/0972-3919.108843
Retrospective Study of 18F-FDG PET/CT in the Diagnosis of Inflammatory Breast Cancer: Preliminary Data, Journal of Nuclear Medicine, vol.50, issue.2, pp.231-238, 2009. ,
DOI : 10.2967/jnumed.108.056010
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment, Annals of Oncology, vol.22, issue.3 ,
DOI : 10.1093/annonc/mdq345
Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes, Annals of Oncology, vol.25, issue.2 ,
DOI : 10.1093/annonc/mdt525
Inflammatory Breast Cancer Management in the National Comprehensive Cancer Network: The Disease, Recurrence Pattern, and Outcome, Clinical Breast Cancer, vol.15, issue.1, pp.1-7, 2015. ,
DOI : 10.1016/j.clbc.2014.05.005
Predictors of Local Recurrence After Breast-Conservation Therapy, Clinical Breast Cancer, vol.5, issue.6, pp.425-438, 2005. ,
DOI : 10.3816/CBC.2005.n.001
Beyond Palliative Mastectomy in Inflammatory Breast Cancer?A Reassessment of Margin Status, Annals of Surgical Oncology, vol.18, issue.3, pp.249-254, 1999. ,
DOI : 10.1007/s10434-999-0249-3
Locoregional Treatment Outcomes After Multimodality Management of Inflammatory Breast Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.2, pp.474-484, 2008. ,
DOI : 10.1016/j.ijrobp.2008.01.039
Prognostic factors in inflammatory breast cancer and therapeutic implications, European Journal of Cancer, vol.30, issue.7, pp.921-927, 1990. ,
DOI : 10.1016/0959-8049(94)90115-5
How Do I Treat Inflammatory Breast Cancer?, Current Treatment Options in Oncology, vol.116, issue.11 Suppl, pp.66-74, 2013. ,
DOI : 10.1007/s11864-012-0214-4
Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy., Journal of Clinical Oncology, vol.4, issue.12, pp.1765-1771, 1986. ,
DOI : 10.1200/JCO.1986.4.12.1765
Inflammatory Carcinoma of the Breast, Surgical Clinics of North America, vol.54, issue.4, pp.801-810, 1974. ,
DOI : 10.1016/S0039-6109(16)40383-X
Inflammatory breast cancer (IBC) and patterns of recurrence, Cancer, vol.10, issue.7, pp.1436-1444, 2007. ,
DOI : 10.1002/cncr.22927
Sequential combined modality therapy for inflammatory breast cancer, Breast, vol.1620, 1976. ,
Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center, Cancer Chemotherapy and Pharmacology, vol.40, issue.4, pp.321-329, 1997. ,
DOI : 10.1007/s002800050664
Paclitaxel in the multimodality treatment for inflammatory breast carcinoma, Cancer, vol.4, issue.7, pp.1775-1782, 2001. ,
DOI : 10.1002/1097-0142(20011001)92:7<1775::AID-CNCR1693>3.0.CO;2-E
Paclitaxel Improves the Prognosis in Estrogen Receptor???Negative Inflammatory Breast Cancer: The M. D. Anderson Cancer Center Experience, Clinical Breast Cancer, vol.4, issue.6, pp.415-419, 2004. ,
DOI : 10.3816/CBC.2004.n.004
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update, Journal of Clinical Oncology, vol.24, issue.12 ,
DOI : 10.1200/JCO.2005.02.6187
Reporting results of cancer treatment, Cancer, vol.11, issue.1, pp.207-214, 1981. ,
DOI : 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6
New Guidelines to Evaluate the Response to Treatment in Solid Tumors, JNCI: Journal of the National Cancer Institute, vol.92, issue.3, pp.205-216, 2000. ,
DOI : 10.1093/jnci/92.3.205
Chemotherapy-induced histologic changes in mastectomy specimens and their potential significance, The Breast, vol.10, issue.6, pp.492-500, 2001. ,
DOI : 10.1054/brst.2001.0310
Inflammatory Breast Cancer, American Journal of Clinical Oncology, vol.16, issue.3, pp.223-228, 1993. ,
DOI : 10.1097/00000421-199306000-00006
Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome, J. Am. Coll. Surg, vol.180, pp.297-79, 1995. ,
Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma, Annals of Surgical Oncology, vol.83, issue.6, pp.452-461, 1997. ,
DOI : 10.1007/BF02303668
Traitement locor??gional du cancer du sein inflammatoire apr??s chimioth??rapie n??oadjuvante, Cancer/Radioth??rapie, vol.15, issue.8, pp.654-662, 2011. ,
DOI : 10.1016/j.canrad.2011.01.009
Primary chemo-radiotherapy in the treatment of locally advanced and inflammatory breast cancer, The Breast, vol.21, issue.3 ,
DOI : 10.1016/j.breast.2012.02.002
Multimodality therapy in inflammatory breast cancer: is there a place for surgery?, Annals of Oncology, vol.11, issue.9, pp.1147-1153, 2000. ,
DOI : 10.1023/A:1008374931854
Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer, International Journal of Surgery, vol.7, issue.3, pp.272-275, 2009. ,
DOI : 10.1016/j.ijsu.2009.04.012
Long-?term Follow-?up of Breast-?conserving Therapy in Patients with Inflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy, Am. Surg, vol.80, pp.940-943, 2014. ,
Esthetic reconstruction after mastectomy for inflammatory breast cancer: is it worthwhile?11No competing interests declared., Journal of the American College of Surgeons, vol.190, issue.3, pp.304-309, 2000. ,
DOI : 10.1016/S1072-7515(99)00267-7
Challenging a Traditional Paradigm, Plastic and Reconstructive Surgery, vol.135, issue.2, pp.262-271, 2015. ,
DOI : 10.1097/PRS.0000000000000900
Usefulness of immediate reconstruction after mastectomy for inflammatory breast cancer with muscle cutaneous flap], Gan To Kagaku Ryoho, vol.38, pp.2165-2167, 2011. ,
The Role of Locoregional Therapy in Inflammatory Breast Cancer, Seminars in Oncology, vol.35, issue.1, pp.78-86, 2008. ,
DOI : 10.1053/j.seminoncol.2007.11.009
Overcoming radiation resistance in inflammatory breast cancer, Cancer, vol.66, issue.1 suppl, pp.2840-2845, 2010. ,
DOI : 10.1002/cncr.25173
Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence, International Journal of Radiation Oncology*Biology*Physics, vol.47, issue.5, pp.1191-1200, 2000. ,
DOI : 10.1016/S0360-3016(00)00561-7
Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy, Cancer, vol.1, issue.11, pp.2535-2544, 2006. ,
DOI : 10.1002/cncr.22227
Collaborative Group (EBCTCG) et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-?level meta-?analysis of randomised trials, Lancet, vol.378, pp.771-784, 2011. ,
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen, Journal of Clinical Oncology, vol.28, issue.3, pp.509-518, 2010. ,
DOI : 10.1200/JCO.2009.23.1274
Adjuvant Ovarian Suppression in Premenopausal Breast Cancer, New England Journal of Medicine, vol.372, issue.5, pp.436-446, 2015. ,
DOI : 10.1056/NEJMoa1412379
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer, New England Journal of Medicine, vol.371, issue.2, pp.107-118, 2014. ,
DOI : 10.1056/NEJMoa1404037
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial, The Lancet, vol.381, issue.9869, pp.805-816, 2013. ,
DOI : 10.1016/S0140-6736(12)61963-1
Adjuvant endocrine therapy for breast cancer: how long is long enough? Oncol, Williston Park N, vol.27, pp.1210-1216, 2013. ,
Systemic treatments of inflammatory breast cancer: an overview, Bull. Cancer (Paris), vol.101, pp.1080-1088, 2014. ,
Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort, The Lancet Oncology, vol.15, issue.6, pp.640-647, 2014. ,
DOI : 10.1016/S1470-2045(14)70080-4
Pathological Response and Circulating Tumor Cell Count Identifies Treated HER2+ Inflammatory Breast Cancer Patients with Excellent Prognosis: BEVERLY-2 Survival Data, Clinical Cancer Research, vol.21, issue.6, 2014. ,
DOI : 10.1158/1078-0432.CCR-14-1705
Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study, The Lancet Oncology, vol.10, issue.6, pp.581-588, 2009. ,
DOI : 10.1016/S1470-2045(09)70087-7
Circulating tumor cells in newly diagnosed inflammatory breast 81 cancer, Breast Cancer Res. BCR, vol.17, 2015. ,
Statin use in primary inflammatory breast cancer: a cohort study, British Journal of Cancer, vol.42, issue.2, pp.318-324, 2013. ,
DOI : 10.1093/carcin/bgh201
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.25, pp.2127-2159, 2007. ,
Maastricht Delphi Consensus on Event Definitions for Classification of Recurrence in Breast Cancer Research, JNCI Journal of the National Cancer Institute, vol.106, issue.12, 2014. ,
DOI : 10.1093/jnci/dju288
Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy, The British Journal of Radiology, vol.84, issue.1003, pp.612-620, 2011. ,
DOI : 10.1259/bjr/74430952
Initial Response to Chemotherapy, Not Delay in Diagnosis, Predicts Overall Survival in Inflammatory Breast Cancer Cases, American Journal of Clinical Oncology, vol.37, issue.4, pp.315-321, 2014. ,
DOI : 10.1097/COC.0b013e318271b34b
Traitement chirurgical conservateur de la récidive locale d'un cancer du sein, 2009. ,
Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM), European Journal of Cancer, vol.35, issue.1, pp.32-38, 1990. ,
DOI : 10.1016/S0959-8049(98)00301-3
Recurrence and death from breast cancer after complete treatments: an experience from hospitals in Northern Thailand, J. Med. Assoc. Thail. Chotmaihet Thangphaet, vol.97, pp.932-938, 2014. ,
Lymph node status in inflammatory breast cancer, Breast Cancer Research and Treatment, vol.375, issue.9712, 2015. ,
DOI : 10.1007/s10549-015-3367-6
Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitude, European Journal of Cancer, vol.51, issue.6, pp.697-704, 1990. ,
DOI : 10.1016/j.ejca.2015.01.063